IPHYF

Innate Pharma (PK) (IPHYF)

Innate Pharma (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:IPHYF

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
05/14/2024	6:07AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
05/07/2024	6:03AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
03/06/2024	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
03/06/2024	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
02/21/2024	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
02/06/2024	5:05PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
02/06/2024	5:00PM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	USOTC:IPHYF	Innate Pharma (PK)
12/19/2023	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
12/18/2023	11:40AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
12/11/2023	6:01AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
12/11/2023	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
11/27/2023	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
11/07/2023	6:01AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
10/16/2023	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
10/05/2023	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
09/22/2023	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
08/10/2023	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
06/26/2023	6:03AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
06/12/2023	6:45AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
06/12/2023	6:44AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
06/08/2023	6:02AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
06/07/2023	6:03AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/26/2023	6:05AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/15/2023	6:28AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/12/2023	4:01PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/10/2023	6:05AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/09/2023	6:05AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
04/26/2023	4:04PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
04/26/2023	4:03PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
04/26/2023	4:02PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:IPHYF	Innate Pharma (PK)